SK Materials has invested $17 million in Group14 Technologies, a US-based startup developing advanced materials that can enhance the energy density of lithium-ion batteries by 50 percent.
The investments will allow Group14 Technologies to ramp up its pilot production facility and help with next year's groundbreaking of a large-scale plant in Washington next year.
SK Materials made the investments together with US-based venture capital firm OVP Venture Partners.
According to SK Materials CEO Lee Young-wook, Group14‘s innovative battery material chemistry called SCC55 maximizes high-quality production. SCC55 can replace conventional graphite materials inside anodes-- one of the four key materials inside lithium-ion batteries.
Group14 Technologies claims that SCC55 can increase a battery’s energy density by 50 percent. The manufacturing process is also much simpler.
Currently, Korean battery makers use graphite mixed with 5 percent silicon for anodes.


Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 



